The Code of Federal Regulations of the United States of AmericaU.S. Government Printing Office, 1993 The Code of Federal Regulations is the codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the Federal Government. |
No grāmatas satura
1.–5. rezultāts no 42.
iii. lappuse
... by Reference ..... 149 Table of CFR Titles and Chapters ...... 151 Alphabetical List of Agencies Appearing in the CFR ....... 167 List of CFR Sections Affected 177 Cite this Code : CFR To cite the regulations in iii.
... by Reference ..... 149 Table of CFR Titles and Chapters ...... 151 Alphabetical List of Agencies Appearing in the CFR ....... 167 List of CFR Sections Affected 177 Cite this Code : CFR To cite the regulations in iii.
v. lappuse
... appears in the Reader Aids section of the daily Federal Register . These two lists will identify the Federal Register page number of the latest amend- ment of any given rule . EFFECTIVE AND EXPIRATION DATES Each volume of the Code ...
... appears in the Reader Aids section of the daily Federal Register . These two lists will identify the Federal Register page number of the latest amend- ment of any given rule . EFFECTIVE AND EXPIRATION DATES Each volume of the Code ...
vii. lappuse
... appearing in the Code of Federal Regulations . INQUIRIES AND SALES For a summary , legal interpretation , or other explanation of any regulation in this volume , contact the issuing agency . Inquiries concerning editing procedures and ...
... appearing in the Code of Federal Regulations . INQUIRIES AND SALES For a summary , legal interpretation , or other explanation of any regulation in this volume , contact the issuing agency . Inquiries concerning editing procedures and ...
ix. lappuse
... appears in the volume containing part 1300 - end . Redesignation tables for Chapter I - Food and Drug Administration appear in the Finding Aids section for the volumes containing parts 170-199 and 500–599 . For this volume , Carol ...
... appears in the volume containing part 1300 - end . Redesignation tables for Chapter I - Food and Drug Administration appear in the Finding Aids section for the volumes containing parts 170-199 and 500–599 . For this volume , Carol ...
4. lappuse
... appear in the upper left corner of the envelope . ( c ) The following statements are to appear in the far left third of the en- velope front , in the type and size indi- cated , centered in a rectangular space approximately 3 inches ...
... appear in the upper left corner of the envelope . ( c ) The following statements are to appear in the far left third of the en- velope front , in the type and size indi- cated , centered in a rectangular space approximately 3 inches ...
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
active ingredient adequate advertisement amended appropriate approved batch bear beling cation chapter chlorcyclizine clinical closures cluding Code contraindications control number Cosmetic Act cyclizine detoxification distribution distributor dosage form dose Drug Administration drug application Drug Enforcement Administration drug establishment drug listing drug prod drug product containers equipment established name evaluation exemption expiration date facture Federal Food Federal Register Food and Drug gram hexachlorophene intended licensed maintenance treatment manu manufac manufacturing meclizine medicated article(s medicated feed ment Methadone misbranded name or designation narcotic narcotic drugs National Office operations oral over-the-counter over-the-counter drug packaging and labeling packing paragraph patient patient's record pernicious anemia person potassium permanganate pregnancy Pregnancy category preparations prescription drugs principal display panel processing program physician proprietary name quired regulations safety sample shipment side effects specific storage submitted Subpart tained testing tients tion treatment program ture Type A medicated ucts
Populāri fragmenti
45. lappuse - Indications Based on a review of this drug by the National Academy of Sciences — National Research Council and/or other information, FDA has classified the indications as follows: Effective: For the management of the manifestations of psychotic disorders.
23. lappuse - There are. however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed...
24. lappuse - ProHance* should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
25. lappuse - Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Lortab 7.5/500 tablets, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
38. lappuse - Labeling on or within the package from which the drug is to be dispensed bears adequate information for its use, including indications, effects, dosages, routes, methods, and frequency and duration of administration, and any relevant hazards, contraindications, side effects, and precautions...
x. lappuse - All prices include regular domestic postage and handling and are subject to change. (Company or personal name) (Additional address/attention line) (Street address) 3.
53. lappuse - The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed...
42. lappuse - REGULATIONS MAKING EXEMPTIONS SEC. 405. The Secretary shall promulgate regulations exempting from any labeling requirement of this Act (1) small open containers of fresh fruits and fresh vegetables and (2) food which is, in accordance with the practice of the trade, to be processed, labeled, or repacked in substantial quantities at establishments other than those where originally processed or packed, on condition that such food is not adulterated or misbranded under the provisions of this Act upon...
25. lappuse - Nursing Mothers: It is not known whether this drug is excreted in human milk Because many drugs are excreted in human milk, caution should be exercised when sucralfate is administered to a nursing woman...
16. lappuse - USP) 2.5. 5, and 10 mg contain FD&C Yellow No. 5 (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible individuals. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen In patients who also have aspirin hypersensitivity.